3,4-dihydroxyphenylglycol and Disease Models, Animal

Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Antidepressive Agents; Chromatography, Liquid; Depression; Disease Models, Animal; Dopamine; Eosine Yellowish-(YS); Hematoxylin; Hippocampus; Homovanillic Acid; Hydroxyindoleacetic Acid; Methoxyhydroxyphenylglycol; Monoamine Oxidase; Neurotransmitter Agents; Norepinephrine; Plant Extracts; Rats; Rehmannia; Serotonin; Serotonin Plasma Membrane Transport Proteins; Stress, Psychological; Tandem Mass Spectrometry; Tryptophan Hydroxylase

Topics: Allosteric Regulation; Animals; Brain Ischemia; CA1 Region, Hippocampal; Disease Models, Animal; Down-Regulation; Gliosis; In Vitro Techniques; Methoxyhydroxyphenylglycol; Neuroglia; Neuroprotective Agents; Phosphatidylinositol 3-Kinases; Piperidines; Proto-Oncogene Proteins c-akt; Rats; Receptor, Metabotropic Glutamate 5; Receptors, AMPA; Receptors, Metabotropic Glutamate

Topics: Animals; Behavior, Animal; Blotting, Western; Chronic Disease; Constriction, Pathologic; Disease Models, Animal; Down-Regulation; Fluorescent Antibody Technique; Gyrus Cinguli; Male; Methoxyhydroxyphenylglycol; Neuralgia; Patch-Clamp Techniques; Pyramidal Cells; Rats; Rats, Sprague-Dawley; Receptors, Metabotropic Glutamate; Sciatic Nerve

Topics: Animals; Arthritis, Rheumatoid; Blotting, Western; Disease Models, Animal; Gene Expression; Male; Methoxyhydroxyphenylglycol; Monoamine Oxidase; Myocardium; Norepinephrine; Norepinephrine Plasma Membrane Transport Proteins; Rats; Real-Time Polymerase Chain Reaction; Receptors, Adrenergic, beta; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Terpenes; Tyrosine 3-Monooxygenase

Topics: Animals; CA1 Region, Hippocampal; Disease Models, Animal; Dose-Response Relationship, Drug; Gene Knockout Techniques; Hippocampus; Learning; Learning Disabilities; Locomotion; Male; Maze Learning; Memory; Memory Disorders; Methoxyhydroxyphenylglycol; Protein Kinase C; Rats; Spatial Memory

Topics: Animals; Baroreflex; Behavior, Animal; Biological Transport; Catecholamines; Disease Models, Animal; Female; Gene Knock-In Techniques; Humans; Methoxyhydroxyphenylglycol; Mice; Mutant Proteins; Norepinephrine; Norepinephrine Plasma Membrane Transport Proteins; Postural Orthostatic Tachycardia Syndrome; Telemetry

Topics: Alzheimer Disease; Animals; CA1 Region, Hippocampal; Calcineurin Inhibitors; Caspase 3; Dendrites; Disease Models, Animal; Disks Large Homolog 4 Protein; Drug Evaluation, Preclinical; Excitatory Postsynaptic Potentials; Guanylate Kinases; Long-Term Synaptic Depression; Male; Membrane Proteins; Methoxyhydroxyphenylglycol; Mice; Mice, Transgenic; Neuroprotective Agents; Phosphorylation; Phosphoserine; Post-Synaptic Density; Protein Processing, Post-Translational; Receptors, AMPA; Receptors, Metabotropic Glutamate; Tacrolimus

Topics: Age Factors; Analysis of Variance; Animals; Anxiety; Basic Helix-Loop-Helix Transcription Factors; Cerebral Cortex; Conditioning, Classical; Depression; Disease Models, Animal; DNA-Binding Proteins; Exploratory Behavior; Extinction, Psychological; Gene Expression Profiling; Gene Expression Regulation; Hippocampus; In Vitro Techniques; Locomotion; Long-Term Synaptic Depression; Male; Maze Learning; Methoxyhydroxyphenylglycol; Mice; Mice, Inbred C57BL; Mice, Knockout; Nerve Tissue Proteins; Neurons; Oligonucleotide Array Sequence Analysis; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-fos; Receptors, N-Methyl-D-Aspartate; Synapses; Synapsins

Topics: Angelman Syndrome; Animals; Carrier Proteins; Disease Models, Animal; Enzyme Inhibitors; Excitatory Amino Acid Antagonists; Hemizygote; Hippocampus; Homer Scaffolding Proteins; Immunosuppressive Agents; In Vitro Techniques; Long-Term Synaptic Depression; Methoxyhydroxyphenylglycol; Mice; Mice, Inbred C57BL; Mice, Transgenic; Mitogen-Activated Protein Kinase Kinases; Pyridines; Receptor, Metabotropic Glutamate 5; Signal Transduction; Sirolimus; Ubiquitin-Protein Ligases

Topics: Adult; Animals; Antioxidants; Disease Models, Animal; Female; Humans; Lipid Peroxidation; Male; Methoxyhydroxyphenylglycol; Microsomes; Middle Aged; Olea; Olive Oil; Phenols; Phenylethyl Alcohol; Plant Extracts; Platelet Aggregation; Rats; Vitamin E; Vitamin E Deficiency

Topics: Animals; Biophysical Phenomena; Cyclic Nucleotide-Gated Cation Channels; Disease Models, Animal; Hyperalgesia; In Vitro Techniques; Male; Membrane Potentials; Methoxyhydroxyphenylglycol; Neuralgia; Pain Measurement; Pain Threshold; Prefrontal Cortex; Pyramidal Cells; Pyrimidines; Rats; Rats, Long-Evans; Sodium Channel Blockers; Synaptic Potentials; Tetrodotoxin

Topics: Amygdala; Analysis of Variance; Animals; Anti-Anxiety Agents; Anxiety; Buprenorphine; Conditioning, Psychological; Conflict, Psychological; Disease Models, Animal; Dose-Response Relationship, Drug; Estradiol; Female; Gene Expression Regulation; Male; Methoxyhydroxyphenylglycol; Ovariectomy; Rats; Rats, Sprague-Dawley; Receptors, Metabotropic Glutamate; Sex Characteristics

Topics: 3,4-Dihydroxyphenylacetic Acid; Amphetamine-Related Disorders; Animals; Chromatography, High Pressure Liquid; Disease Models, Animal; Illicit Drugs; Male; Methamphetamine; Methoxyhydroxyphenylglycol; Norepinephrine; Rats; Reproduction; Testis

Topics: Animals; Cell Differentiation; Cerebral Cortex; Disease Models, Animal; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; Female; Fragile X Syndrome; Humans; Male; Methoxyhydroxyphenylglycol; Mice; Mice, Inbred C57BL; Mice, Knockout; N-Methylaspartate; Neural Stem Cells; Pyridines; Receptor, Metabotropic Glutamate 5

Topics: Age Factors; Animals; Biophysics; CA3 Region, Hippocampal; Disease Models, Animal; Electric Stimulation; Excitatory Amino Acid Agents; Excitatory Postsynaptic Potentials; Fragile X Mental Retardation Protein; Fragile X Syndrome; In Vitro Techniques; Long-Term Synaptic Depression; Male; Methoxyhydroxyphenylglycol; Mice; Mice, Inbred C57BL; Mice, Knockout; Receptors, N-Methyl-D-Aspartate; Signal Transduction; Synapses

Topics: Amino Acids; Animals; Antidepressive Agents, Tricyclic; Behavior, Animal; Bridged Bicyclo Compounds, Heterocyclic; Clomipramine; Colforsin; Cyclic AMP; Depression; Disease Models, Animal; Drug Interactions; Gene Expression Regulation; Hippocampus; In Vitro Techniques; Methoxyhydroxyphenylglycol; Rats; Receptors, Metabotropic Glutamate; RNA, Messenger; Swimming

Topics: Analysis of Variance; Animals; Animals, Newborn; Brain Ischemia; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme Inhibitors; Excitatory Amino Acid Antagonists; Glutamic Acid; Hippocampus; Methoxyhydroxyphenylglycol; Oncogene Protein v-akt; Organ Culture Techniques; Phosphatidylinositol 3-Kinases; Propidium; Pyramidal Cells; Rats; Rats, Wistar; Receptors, Metabotropic Glutamate; Signal Transduction; Time Factors

Topics: Adaptor Proteins, Signal Transducing; Animals; CA1 Region, Hippocampal; Carrier Proteins; Cell Cycle Proteins; Cognition Disorders; Disease Models, Animal; Eukaryotic Initiation Factor-4A; Eukaryotic Initiation Factors; Excitatory Postsynaptic Potentials; Fragile X Mental Retardation Protein; Fragile X Syndrome; Gene Expression Regulation; Immunoprecipitation; In Vitro Techniques; Long-Term Synaptic Depression; Methoxyhydroxyphenylglycol; Mice; Mice, Knockout; Oncogene Protein v-akt; Phosphatidylinositol 3-Kinases; Phosphoproteins; Phosphorylation; Receptors, Metabotropic Glutamate; Serine; Signal Transduction; Sirolimus

Topics: Analysis of Variance; Animals; Cells, Cultured; Class I Phosphatidylinositol 3-Kinases; Dendrites; Disease Models, Animal; Embryo, Mammalian; Enzyme Inhibitors; Excitatory Amino Acid Antagonists; Fragile X Mental Retardation Protein; Fragile X Syndrome; Gene Expression Regulation, Enzymologic; Green Fluorescent Proteins; Hippocampus; Humans; Immunoprecipitation; Luminescent Proteins; Methoxyhydroxyphenylglycol; Mice; Mice, Knockout; Models, Biological; Neurons; Phosphatidylinositol 3-Kinases; Protein Subunits; Receptors, AMPA; Red Fluorescent Protein; RNA, Messenger; Synapses; Synaptosomes; Transfection

Topics: Age Factors; Analysis of Variance; Animals; Animals, Newborn; Benzopyrans; Cells, Cultured; Dendritic Spines; Disease Models, Animal; Fragile X Mental Retardation Protein; Fragile X Syndrome; Hippocampus; Methoxyhydroxyphenylglycol; Mice; Mice, Inbred C57BL; Mice, Knockout; Neural Inhibition; Neurons; Pyridines; Receptors, Metabotropic Glutamate; Signal Transduction; Silver Staining

Topics: Aminoquinolines; Analysis of Variance; Animals; Brain; Dendrites; Dendritic Spines; Disease Models, Animal; Electric Stimulation; Excitatory Amino Acid Antagonists; Excitatory Postsynaptic Potentials; Fragile X Mental Retardation Protein; Fragile X Syndrome; Gene Expression Regulation; In Vitro Techniques; Methoxyhydroxyphenylglycol; Mice; Mice, Inbred C57BL; Mice, Transgenic; Neurons; Patch-Clamp Techniques; Pyrimidines; rac1 GTP-Binding Protein; Signal Transduction; Silver Staining; Synapses

Topics: Action Potentials; Animals; Arthritis, Experimental; Benzoates; Bicuculline; Disease Models, Animal; Electrophysiology; Excitatory Amino Acid Antagonists; GABA Antagonists; gamma-Aminobutyric Acid; Glycine; Male; Methoxyhydroxyphenylglycol; Neurons; Pain; Prefrontal Cortex; Rats; Rats, Sprague-Dawley; Receptor, Metabotropic Glutamate 5; Receptors, GABA-A; Receptors, Metabotropic Glutamate

Topics: Animals; Attention Deficit Disorder with Hyperactivity; Cocaine; Corpus Striatum; Disease Models, Animal; Dopamine Plasma Membrane Transport Proteins; Dopamine Uptake Inhibitors; Dronabinol; Excitatory Amino Acid Antagonists; Food Preferences; Gene Expression Regulation; In Vitro Techniques; Inhibitory Postsynaptic Potentials; Male; Methoxyhydroxyphenylglycol; Mice; Mice, Inbred C57BL; Mice, Transgenic; Motor Activity; Point Mutation; Receptor, Cannabinoid, CB1; Receptors, GABA-B; Sucrose

Topics: Analysis of Variance; Animals; Disease Models, Animal; Down Syndrome; Electric Stimulation; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; Excitatory Postsynaptic Potentials; Hippocampus; In Vitro Techniques; Long-Term Synaptic Depression; Memantine; Methoxyhydroxyphenylglycol; Mice; Mice, Mutant Strains; N-Methylaspartate; Time Factors; Trisomy

Topics: Analysis of Variance; Animals; Animals, Newborn; Biophysics; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Disease Models, Animal; Dose-Response Relationship, Drug; Electric Stimulation; Enzyme Inhibitors; Excitatory Amino Acid Agents; GTPase-Activating Proteins; Hippocampus; In Vitro Techniques; Long-Term Synaptic Depression; MAP Kinase Signaling System; Methoxyhydroxyphenylglycol; Mice; Mice, Inbred C57BL; Mice, Transgenic; Patch-Clamp Techniques; Receptors, Metabotropic Glutamate; Ribosomal Protein S6 Kinases; Tuberous Sclerosis; Tuberous Sclerosis Complex 1 Protein; Tuberous Sclerosis Complex 2 Protein; Tumor Suppressor Proteins

Topics: Analysis of Variance; Animals; Carrier Proteins; Cycloheximide; Disease Models, Animal; Electric Stimulation; Exploratory Behavior; Fragile X Mental Retardation Protein; Fragile X Syndrome; Gene Expression Regulation; Hippocampus; Homer Scaffolding Proteins; Immunoprecipitation; In Vitro Techniques; Long-Term Potentiation; Methoxyhydroxyphenylglycol; Mice; Mice, Inbred C57BL; Mice, Transgenic; Mutation; Nerve Net; Patch-Clamp Techniques; Peptides; Physics; Protein Synthesis Inhibitors; Rats; Rats, Long-Evans; Receptor, Metabotropic Glutamate 5; Receptors, Metabotropic Glutamate; Serine; Signal Transduction; TOR Serine-Threonine Kinases

Topics: Acetylcysteine; Animals; Apoptosis; Cell Line; Cell Survival; Disease Models, Animal; Enzyme Inhibitors; Extracellular Signal-Regulated MAP Kinases; Free Radical Scavengers; Methoxyhydroxyphenylglycol; Oxidation-Reduction; Parkinson Disease; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Receptors, Metabotropic Glutamate; Staurosporine

Topics: Aldehyde Dehydrogenase; Aldehyde Dehydrogenase, Mitochondrial; Animals; Anticholesteremic Agents; Antioxidants; Diet; Dietary Supplements; Disease Models, Animal; Food-Processing Industry; Fruit; Hypolipidemic Agents; Industrial Waste; Intestinal Absorption; Liver; Male; Methoxyhydroxyphenylglycol; Mitochondrial Proteins; Olea; Oxidative Stress; Phenylethyl Alcohol; Plant Extracts; Random Allocation; Rats; Vitamin E Deficiency

Topics: Adaptor Proteins, Signal Transducing; Animals; Behavior, Animal; Disease Models, Animal; DNA Copy Number Variations; Excitatory Amino Acid Antagonists; Fragile X Syndrome; Gene Order; Genotype; Haploinsufficiency; Long-Term Potentiation; Long-Term Synaptic Depression; Male; Methoxyhydroxyphenylglycol; Mice; Mice, Knockout; Nerve Tissue Proteins; Phenotype; Protein Biosynthesis; Receptors, Glutamate

Topics: Analysis of Variance; Animals; Behavior, Animal; Biophysics; Dendritic Spines; Disease Models, Animal; Electric Stimulation; Excitatory Postsynaptic Potentials; Exploratory Behavior; Extracellular Signal-Regulated MAP Kinases; Female; Fragile X Mental Retardation Protein; Fragile X Syndrome; Gene Expression Regulation; Hippocampus; In Vitro Techniques; Interpersonal Relations; Long-Term Synaptic Depression; Male; Maze Learning; Membrane Potentials; Methoxyhydroxyphenylglycol; Mice; Mice, Inbred C57BL; Mice, Transgenic; Motor Activity; Mutation; Neurons; Patch-Clamp Techniques; Phenotype; Phosphorylation; Recognition, Psychology; Ribosomal Protein S6 Kinases, 70-kDa; Rotarod Performance Test; Synapses; TOR Serine-Threonine Kinases

Topics: Action Potentials; Animals; Blotting, Western; Calcium; Calcium Channels; Calcium Signaling; Cells, Cultured; Cerebellum; Cerebral Cortex; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Fura-2; Green Fluorescent Proteins; Humans; Huntingtin Protein; Huntington Disease; Inositol 1,4,5-Trisphosphate; Inositol 1,4,5-Trisphosphate Receptors; Lipid Bilayers; Luminescent Proteins; Methoxyhydroxyphenylglycol; Nerve Tissue Proteins; Neurons; Nuclear Proteins; Patch-Clamp Techniques; Peptide Fragments; Plasmids; Protein Binding; Receptors, Cytoplasmic and Nuclear; Recombinant Proteins; Time Factors; Two-Hybrid System Techniques

Topics: Amino Acids, Dicarboxylic; Animals; Autoradiography; Basal Ganglia; Behavior, Animal; Disease Models, Animal; Dose-Response Relationship, Drug; Excitatory Amino Acid Agonists; Glucose; Immunohistochemistry; Methoxyhydroxyphenylglycol; Oxidopamine; Parkinson Disease; Proto-Oncogene Proteins c-fos; Rats; Receptors, Metabotropic Glutamate

Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Action Potentials; Animals; Behavior, Animal; Benzoates; Cell Count; Disease Models, Animal; Down-Regulation; Drug Interactions; Excitatory Amino Acid Antagonists; Female; Globus Pallidus; Glycine; Immunohistochemistry; Indans; Macaca fascicularis; Male; Methoxyhydroxyphenylglycol; Parkinsonian Disorders; Receptors, Metabotropic Glutamate; Severity of Illness Index; Substantia Nigra; Tyrosine 3-Monooxygenase

Topics: Amyotrophic Lateral Sclerosis; Animals; Animals, Genetically Modified; Aspartic Acid; Astrocytes; Blotting, Northern; Calcium; Carbachol; Cholinergic Agonists; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Excitatory Amino Acid Antagonists; Excitatory Amino Acid Transporter 2; Gene Expression Regulation; Glial Fibrillary Acidic Protein; Glutamic Acid; Humans; Immunohistochemistry; Male; Methoxyhydroxyphenylglycol; Protein Kinase C; Pyridines; Rats; Receptor, Metabotropic Glutamate 5; Receptors, Metabotropic Glutamate; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Sodium; Superoxide Dismutase; Tritium

Topics: 2-Amino-5-phosphonovalerate; Animals; Anisomycin; Blotting, Western; Disease Models, Animal; Drug Interactions; Electric Stimulation; Excitatory Amino Acid Antagonists; Fragile X Mental Retardation Protein; Fragile X Syndrome; Hippocampus; In Vitro Techniques; Long-Term Synaptic Depression; Methoxyhydroxyphenylglycol; Mice; Mice, Knockout; Neurons; Protein Biosynthesis; Protein Synthesis Inhibitors; Receptors, Metabotropic Glutamate

Topics: Animals; Carrier Proteins; Disease Models, Animal; Dose-Response Relationship, Radiation; Down-Regulation; Electric Stimulation; Hippocampus; Homer Scaffolding Proteins; In Vitro Techniques; Long-Term Synaptic Depression; Male; Methoxyhydroxyphenylglycol; Neurons; Pilocarpine; Rats; Rats, Wistar; Receptors, Metabotropic Glutamate; Status Epilepticus

Topics: Analysis of Variance; Animals; Behavior, Animal; Chromatography, Liquid; Disease Models, Animal; Dopamine; Electroencephalography; Extracellular Fluid; gamma-Aminobutyric Acid; Glutamic Acid; Hippocampus; Male; Methoxyhydroxyphenylglycol; Microdialysis; Picrotoxin; Pilocarpine; Rats; Rats, Wistar; Seizures; Serotonin; Statistics, Nonparametric; Time Factors

Topics: Animals; Anti-Arrhythmia Agents; Antihypertensive Agents; Arrhythmias, Cardiac; Atrasentan; Blotting, Western; Bosentan; Cardiac Pacing, Artificial; Disease Models, Animal; Endothelin A Receptor Antagonists; Endothelin B Receptor Antagonists; Endothelin-1; GAP-43 Protein; Hemodynamics; Hydralazine; Immunohistochemistry; Male; Methoxyhydroxyphenylglycol; Myocardial Infarction; Myocardium; Nerve Growth Factor; Neurofilament Proteins; Norepinephrine; Polymerase Chain Reaction; Pyrrolidines; Rats; Rats, Wistar; Receptor, Endothelin A; Receptor, Endothelin B; RNA, Messenger; Sulfonamides; Sympathetic Nervous System; Time Factors; Tyrosine 3-Monooxygenase; Up-Regulation

Topics: Adrenergic Agents; Analysis of Variance; Animals; Behavior, Animal; Dioxolanes; Disease Models, Animal; Drug Interactions; Excitatory Amino Acid Antagonists; Female; Globus Pallidus; Methoxyhydroxyphenylglycol; Motor Activity; Oxidopamine; Parkinson Disease; Proto-Oncogene Proteins c-fos; Purines; Rats; Rats, Sprague-Dawley; Receptors, Metabotropic Glutamate; Substantia Nigra; Time Factors; Tyrosine 3-Monooxygenase

Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Brain; Brain Chemistry; Catecholamines; Dihydroxyphenylalanine; Disease Models, Animal; Dopamine; Hepatectomy; Hepatic Encephalopathy; Hydroxylation; Male; Methoxyhydroxyphenylglycol; Norepinephrine; Oxidation-Reduction; Rats; Rats, Sprague-Dawley; Subcellular Fractions; Tissue Distribution

Topics: Animals; Cold Temperature; Disease Models, Animal; Heart Transplantation; Lactates; Lactic Acid; Male; Methoxyhydroxyphenylglycol; Norepinephrine; Organ Preservation; Perfusion; Pyruvates; Pyruvic Acid; Random Allocation; Swine; Swine, Miniature

Topics: 3,4-Dihydroxyphenylacetic Acid; Acute Disease; Animals; Chronic Disease; Dialysis; Disease Models, Animal; Male; Methoxyhydroxyphenylglycol; Norepinephrine; Paraventricular Hypothalamic Nucleus; Random Allocation; Rats; Rats, Sprague-Dawley; Restraint, Physical; Stress, Physiological

Topics: Animals; Catecholamines; Coronary Vessels; Disease Models, Animal; Female; Glycols; Heart Failure; Methoxyhydroxyphenylglycol; Myocardium; Organ Size; Rats; Rats, Inbred Strains

Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Catecholamines; Disease Models, Animal; Dopamine; Homovanillic Acid; Hypertension, Portal; Liver Cirrhosis, Experimental; Male; Methoxyhydroxyphenylglycol; Norepinephrine; Rats; Rats, Inbred Strains; Vanilmandelic Acid